Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Product Description

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) is a premium peptide blend formulated for laboratory and research applications. This synergistic combination contains Fragment 176-191 (6mg), CJC-1295 No DAC (3mg), and Ipamorelin (3mg) in a lyophilized powder form with high purity standards.

Fragment 176-191 is a modified segment of human growth hormone that has been studied for its potential role in fat metabolism. CJC-1295 No DAC is a Growth Hormone Releasing Hormone (GHRH) analog designed to support natural growth hormone signaling, while Ipamorelin is a selective Growth Hormone Secretagogue (GHS) investigated for its ability to stimulate growth hormone release through ghrelin receptors. When combined, these peptides are commonly utilized in research exploring body composition, recovery processes, and growth hormone dynamics.

For Research Use Only. Not intended for human consumption, medical use, diagnosis, or treatment.

Product Specifications

• Product Name: Fragment 176-191 & CJC-1295 & Ipamorelin Blend
• Strength: 12mg
• Composition:
  • Fragment 176-191 – 6mg
  • CJC-1295 No DAC – 3mg
  • Ipamorelin – 3mg
• Form: Lyophilized Powder
• Purity: ≥99%
• Grade: Research Grade
• Storage: Store refrigerated at 2°C–8°C before reconstitution
• Packaging: Sterile Glass Vial
• Country of Origin: USA/Imported (as applicable)

Key Features

✔ High Purity Research Peptide Blend

✔ Convenient 6mg/3mg/3mg Combination

✔ Laboratory-Tested Quality

✔ Stable Lyophilized Formulation

✔ Suitable for Scientific Research Applications

✔ Secure Packaging